ZA873091B - Pulsed drug delivery - Google Patents

Pulsed drug delivery

Info

Publication number
ZA873091B
ZA873091B ZA873091A ZA873091A ZA873091B ZA 873091 B ZA873091 B ZA 873091B ZA 873091 A ZA873091 A ZA 873091A ZA 873091 A ZA873091 A ZA 873091A ZA 873091 B ZA873091 B ZA 873091B
Authority
ZA
South Africa
Prior art keywords
drug delivery
pulsed drug
pulsed
delivery
drug
Prior art date
Application number
ZA873091A
Other languages
English (en)
Inventor
Atul Devdatt Ayer
Devdatt Ayer Atul
Felix Theeuwes
Theeuwes Felix
Patrick S-L Wong
S-L Wong Patrick
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ZA873091B publication Critical patent/ZA873091B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
ZA873091A 1986-05-09 1987-04-29 Pulsed drug delivery ZA873091B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/861,188 US4842867A (en) 1986-05-09 1986-05-09 Pulsed drug delivery of doxylamine

Publications (1)

Publication Number Publication Date
ZA873091B true ZA873091B (en) 1987-12-30

Family

ID=25335124

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA873091A ZA873091B (en) 1986-05-09 1987-04-29 Pulsed drug delivery

Country Status (14)

Country Link
US (1) US4842867A (xx)
JP (2) JPS62298529A (xx)
KR (1) KR950010144B1 (xx)
AU (1) AU621030B2 (xx)
BE (1) BE1000232A5 (xx)
CA (1) CA1297368C (xx)
CH (1) CH671696A5 (xx)
DE (1) DE3715224C2 (xx)
ES (1) ES2005571A6 (xx)
FR (1) FR2598319B1 (xx)
IT (1) IT1208883B (xx)
NL (1) NL193308C (xx)
SE (1) SE502684C2 (xx)
ZA (1) ZA873091B (xx)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141752A (en) * 1986-05-09 1992-08-25 Alza Corporation Delayed drug delivery device
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
IL88083A (en) * 1987-11-06 1992-11-15 Tanabe Seiyaku Co Controlled release pharmaceutical dosage form and its preparation
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5200197A (en) * 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5045082A (en) * 1990-01-10 1991-09-03 Alza Corporation Long-term delivery device including loading dose
US5071607A (en) * 1990-01-31 1991-12-10 Alza Corporatino Method and apparatus for forming a hole in a drug dispensing device
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5252338A (en) * 1991-06-27 1993-10-12 Alza Corporation Therapy delayed
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5190765A (en) * 1991-06-27 1993-03-02 Alza Corporation Therapy delayed
US5209746A (en) * 1992-02-18 1993-05-11 Alza Corporation Osmotically driven delivery devices with pulsatile effect
US5308348A (en) * 1992-02-18 1994-05-03 Alza Corporation Delivery devices with pulsatile effect
US5456679A (en) * 1992-02-18 1995-10-10 Alza Corporation Delivery devices with pulsatile effect
US5221278A (en) * 1992-03-12 1993-06-22 Alza Corporation Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
CA2141459A1 (en) * 1992-07-31 1994-02-17 Richard Yu Controlled release implants
US5391378A (en) * 1993-02-22 1995-02-21 Elizabeth-Hata International, Inc. Two-part medicinal tablet and method of manufacture
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5718700A (en) * 1994-09-20 1998-02-17 Alza Corporation Exit means in dosage form
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US6096339A (en) * 1997-04-04 2000-08-01 Alza Corporation Dosage form, process of making and using same
AU3909597A (en) * 1996-08-16 1998-03-06 Alza Corporation Dosage form for providing ascending dose of drug
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US5788987A (en) 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US6962997B1 (en) 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
NZ503086A (en) * 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
US6599529B1 (en) * 1997-09-11 2003-07-29 Nycomed Danmark A/S Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (NSAIDs)
US6372254B1 (en) * 1998-04-02 2002-04-16 Impax Pharmaceuticals Inc. Press coated, pulsatile drug delivery system suitable for oral administration
US6551613B1 (en) * 1998-09-08 2003-04-22 Alza Corporation Dosage form comprising therapeutic formulation
EP1112060B1 (en) * 1998-09-09 2005-12-07 ALZA Corporation Dosage form comprising liquid formulation
CN1325301A (zh) * 1998-11-02 2001-12-05 阿尔扎有限公司 活性物质的控制释放
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
JP2004529902A (ja) * 2001-03-13 2004-09-30 ペンウェスト ファーマシューティカルズ カンパニー グルココルチコステロイドを含有する時間治療（ｃｈｒｏｎｏｔｈｅｒａｐｅｕｔｉｃ）投与形態
EP1492509A1 (en) * 2001-12-18 2005-01-05 ALZA Corporation Dosage form providing time-varying patterns of drug delivery
JP4417110B2 (ja) * 2001-12-19 2010-02-17 株式会社三和化学研究所 放出制御型成型品
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US20050208132A1 (en) * 2002-07-29 2005-09-22 Gayatri Sathyan Methods and dosage forms for reducing side effects of benzisozazole derivatives
EP1539270A1 (en) * 2002-09-18 2005-06-15 Medtronic Vascular, Inc. Controllable drug releasing gradient coatings for medical devices
AU2003287301A1 (en) * 2002-10-31 2004-06-07 Alza Corporation Dosage form providing ascending release of liquid formulation
CN1882316A (zh) * 2003-09-19 2006-12-20 宾韦斯特医药公司 延迟释放剂型
US20050118267A1 (en) * 2003-09-19 2005-06-02 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
DE102008059206A1 (de) * 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
US8795727B2 (en) 2009-11-09 2014-08-05 Spotlight Technology Partners Llc Fragmented hydrogels
US9700650B2 (en) 2009-11-09 2017-07-11 Spotlight Technology Partners Llc Polysaccharide based hydrogels
WO2013123569A1 (en) * 2012-02-22 2013-08-29 Duchesnay Inc. Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
AU2013224598B2 (en) 2012-02-22 2015-09-17 Duchesnay Inc. Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
US9452181B2 (en) 2013-07-22 2016-09-27 Duchesnay Inc. Composition for the management of nausea and vomiting
PL3024466T3 (pl) 2013-07-22 2018-08-31 Duchesnay Inc. Kompozycja do kontrolowania nudności i wymiotów
US9526703B2 (en) 2014-08-29 2016-12-27 Duchesnay Inc. Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4298003A (en) * 1980-05-12 1981-11-03 Alza Corporation System for delivering agent at zero order rate with emerging agent below saturation
US4439196A (en) * 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom

Also Published As

Publication number Publication date
DE3715224A1 (de) 1987-11-12
FR2598319A1 (fr) 1987-11-13
KR870010866A (ko) 1987-12-18
SE8701900L (sv) 1987-11-10
FR2598319B1 (fr) 1989-12-01
AU7183787A (en) 1987-11-12
JPS62267221A (ja) 1987-11-19
CH671696A5 (xx) 1989-09-29
KR950010144B1 (ko) 1995-09-11
SE8701900D0 (sv) 1987-05-08
DE3715224C2 (de) 1997-02-20
JPS62298529A (ja) 1987-12-25
NL193308C (nl) 1999-06-02
JPH07116018B2 (ja) 1995-12-13
IT8767393A0 (it) 1987-05-07
US4842867A (en) 1989-06-27
NL8701102A (nl) 1987-12-01
BE1000232A5 (fr) 1988-09-20
CA1297368C (en) 1992-03-17
NL193308B (nl) 1999-02-01
AU621030B2 (en) 1992-03-05
IT1208883B (it) 1989-07-10
SE502684C2 (sv) 1995-12-11
ES2005571A6 (es) 1989-03-16

Similar Documents

Publication Publication Date Title
ZA873091B (en) Pulsed drug delivery
GB8710094D0 (en) Pulsed drug delivery
GB8712975D0 (en) Drug delivery device
EP0232155A3 (en) Drug delivery system
GB8712176D0 (en) Drug delivery system
GB8609218D0 (en) Drug delivery device
GB8630273D0 (en) Pharmaceutical delivery systems
NZ220178A (en) Pulsatile drug delivery system
EP0237263A3 (en) Transdermal drug delivery system
GB8502156D0 (en) Drug delivery
IL86802A0 (en) Drug delivery devices
CS8700282A2 (en) Nicorandil-containing stable pharmaceutical
ZA898323B (en) Pharmaceutical solution
ZA877699B (en) Pharmaceutical combination
IL82675A0 (en) Drug delivery apparatus
EP0305902A3 (en) Medicament
GB8613382D0 (en) Drug delivery device
GB8622697D0 (en) Drug delivery device
GB8620226D0 (en) Drug delivery device
GB8706780D0 (en) Drug delivery device
GB8616617D0 (en) Drug delivery system
IL80330A0 (en) Drug delivery system
IE862619L (en) Lipoprotein-based drug delivery systems
GB8715911D0 (en) Drug delivery device
PH23808A (en) Novel drug delivery system